Marlborough, MA, United States of America

Gavin C Hirst

This inventor holds 33 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Abbott Laboratories Corporation, Rempex Pharmaceuticals, Inc., Abbott Gmbh & Co Kg. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gavin C Hirst. Retrieved from https://idiyas.com/inventor/gavin-c-hirst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 33 (Patent Applications = 3)

% Patents Active = 84.8

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 8.3

ph-index = 12

Forward Citations = 1,101(Granted Patents)

Location History:

Malborough, MA (US) (2004)
Marlborough, MA (US) (2003 - 2008)
Marlboro, MA (US) (2011)
Princeton, MA (US) (2007 - 2013)
San Diego, CA (US) (2010 - 2024)

Company Filing History:

10 out of 4,190

Abbott Laboratories Corporation

patents

8 out of 27

Rempex Pharmaceuticals, Inc.

Janssen Pharmaceutica Nv

patents

5. 3 out of 15

Melinta Subsidiary Corp.

patents

6. 2 out of 17

Sgx Pharmaceuticals, Inc.

Endosome Therapeutics, Inc.

patent

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Antigen Presentation

Cyclic Boronic Acid

Kinase Inhibitors

Protein-Protein Interaction

Therapeutic Uses

Endosomal G Protein-Coupled Receptors

Amino-Tetrazoles

Fused Ring Heterocycles

Polybasic Bacterial Efflux Pump

Substituted Pyrrolopyridines

Pyrazolopyrimidines

Thienopyridines

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516038 - Inhibitors of antigen presentation by HLA-DR (2026-01-06),

2. 12171772 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2024-12-24),

3. 11897900 - Inhibitors of KEAP1-Nrf2 protein-protein interaction (2024-02-13),

4. 11684629 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2023-06-27),

5. 11427601 - Inhibitors of KEAP1-Nrf2 protein-protein interaction (2022-08-30),

6. 11324832 - Tripartite modulators of endosomal G protein-coupled receptors (2022-05-10),

7. 11090319 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2021-08-17),

8. 10947252 - Inhibitors of KEAP1-Nrf2 protein-protein interaction (2021-03-16),

9. 10639318 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2020-05-05),

10. 10183034 - Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2019-01-22),

11. 10172874 - Pharmaceutical compositions comprising cyclic boronic acid ester derivatives (2019-01-08),

12. 10004758 - Cyclic boronic acid ester derivatives and methods of making the same (2018-06-26),

13. 9694025 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2017-07-04),

14. 9296763 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2016-03-29),

15. 8680136 - Cyclic boronic acid ester derivatives and therapeutic uses thereof (2014-03-25),

Title: Gavin C Hirst - Pioneering Inventor from Marlborough

Introduction: Gavin C Hirst is a distinguished inventor based in Marlborough, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Gavin C Hirst holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and innovative spirit.

Career Highlights: With a career spanning over two decades, Gavin C Hirst has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have impacted industries worldwide.

Collaborations: Throughout his career, Gavin C Hirst has collaborated with leading companies, research institutions, and universities, fostering a culture of innovation and knowledge sharing.

Conclusion: Gavin C Hirst's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.